Research Technician I, Inhalation:
Charles River Laboratories, Inc.

Charles River Laboratories, Inc.
Ashland Ohio

For nearly 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work e perform. In return, we’ll help you build a career that you can feel passionate about.

Essential Duties and Responsibilities: 

•Set-up/operate exposure atmosphere generation systems
•Assist co-workers in troubleshooting advanced generation systems
•Write reports for atmosphere characterizations
•Function as lead technician for complex studies 
•Advanced dosing procedures 
•Computerized study randomization 
•Assist in QA Audits 
•Advanced editing of computerized data 
•Assist in training of other personnel



An AS or BS degree in Chemistry, Physics, Biology, Animal Science, Zoology, or a related field is preferred as well as a willingness to learn and an interest in the field of research.  Unrelated degrees will also be considered as well as experience with troubleshooting HVAC systems, auto mechanics and agricultural experience.  We offer a competitive compensation package and benefits.  We offer a competitive compensation package and benefits including 3 weeks of vacation as well as paid sick time and holidays.  Tuition reimbursement is also available.  Charles River Ashland is located in North-central Ohio, with easy accessibility to Cleveland, Columbus, and a variety of cultural and recreational activities.  

Equal Employment Opportunity


Charles River Laboratories, Inc. is an Equal Opportunity Employer M/F/Disabled/Vet


About Safety Assessment

Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market.  Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.

About Charles River

Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

With over 11,000 employees within 70 facilities in 18 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges.  Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2016, revenue increased by 23.3% to $1.68 billion from $1.36 billion in 2015. 

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~70% of the drugs approved by the FDA in 2016.

For more information, please visit

Basic Qualifications